z-logo
open-access-imgOpen Access
Role of surface oxygen-containing functional groups of graphene oxide quantum dots on amyloid fibrillation of two model proteins
Author(s) -
Ebrahim Rostampour Ghareghozloo,
Mohsen Mahdavimehr,
Ali Akbar Meratan,
Nasser Nikfarjam,
Ali Ghasemi,
Bentolhoda Katebi,
Mohsen NematGorgani
Publication year - 2020
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0244296
Subject(s) - graphene , chemistry , ascorbic acid , nanoparticle , zeta potential , oxide , biophysics , materials science , nanotechnology , biology , organic chemistry , food science
There are many reports demonstrating that various derivatives of carbon nanoparticles are effective inhibitors of protein aggregation. As surface structural features of nanoparticles play a key role on modulating amyloid fibrillation process, in the present in vitro study, bovine insulin and hen egg white lysozyme (HEWL) were selected as two model proteins to investigate the reducing effect of graphene oxide quantum dots (GOQDs) on their assembly under amyloidogenic conditions. GOQDs were prepared through direct pyrolysis of citric acid, and the reduction step was carried out using ascorbic acid. The prepared nanoparticles were characterized by UV-Vis, X-ray photoelectron, and FT-IR spectroscopies, transmission electron and atomic force microscopies, zeta potential measurement, and Nile red fluorescence assay. They showed the tendencies to modulate the assembly of the proteins through different mechanisms. While GOQDs appeared to have the capacity to inhibit fibrillation, the presence of reduced GOQDs (rGOQDs) was found to promote protein assembly via shortening the nucleation phase, as suggested by ThT fluorescence data. Moreover, the structures produced in the presence of GOQDs or rGOQDs were totally nontoxic. We suggest that surface properties of these particles may be part of the differences in their mechanism(s) of action.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here